Study: More Than Half of People Taking HIV PrEP Discontinue Use

More than half of individuals who started HIV pre-exposure prophylaxis (PrEP) in a large Northern California care management organization discontinued PrEP in a 6½-year study period, researchers report. African American and Latinx individuals, women, and participants with substance use disorder were more likely to experience gaps in the PrEP care continuum, from initial contact with a provider to adherence over time. […]

Read more

CUNY SPH and NYC Health Department receive grant to study long-acting injectables for HIV

The National Institute of Mental Health (NIMH) has awarded the CUNY Graduate School of Public Health and Health Policy (CUNY SPH) and the New York City Department of Health and Mental Hygiene (NYC Health Department) a thirty month grant to support long-acting injectable antiretroviral therapy access, uptake, and adherence among people with HIV enrolled in the Ryan White HIV/AIDS Program […]

Read more

Human immune cells have natural alarm system against HIV

Treatment for HIV has improved tremendously over the past 30 years; once a death sentence, the disease is now a manageable lifelong condition in many parts of the world. Life expectancy is about the same as that of individuals without HIV, though patients must adhere to a strict regimen of daily antiretroviral therapy, or the virus will come out of […]

Read more

Nivestim

NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. NIVESTIM® Filgrastim [rbe] (fil-GRAS-tim) Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about Nivestim. It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist. All medicines have risks and benefits. […]

Read more

Terry White Chemists Simvastatin

NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. TERRY WHITE CHEMISTS SIMVASTATIN TABLETS Simvastatin Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about simvastatin. It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist. All medicines have risks […]

Read more

Reyataz

NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. REYATAZ® (Ray-uh-taz) Atazanavir (Ata-zan-a-vir) Consumer Medicine Information What is in this leaflet Read this leaflet carefully before taking REYATAZ. This leaflet answers some common questions about REYATAZ. It does not contain all the available information. It does not take the place of talking to your doctor or […]

Read more

Aldiq

NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. ALDIQ imiquimod Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about ALDIQ. It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist. All medicines have risks and benefits. Your doctor […]

Read more
1 2 3 4